Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance.
- NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_assertion description "[Sensitivity of the prostate cancer antigen 3 test could be improved by the detection of the fusion gene transcripts transmembrane protease serine 2-E26 transformation specific-related gene and serine peptidase inhibitor Kazal type 1 who may in addition allow the identification of prostate cancer patients at higher risk of life-threatening disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance.
- NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_assertion evidence source_evidence_literature NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance.
- NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_assertion SIO_000772 19325493 NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance.
- NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_assertion wasDerivedFrom befree-2016 NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance.
- NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_assertion wasGeneratedBy ECO_0000203 NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance.
- befree-2016 importedOn "2016-02-19" NP728798.RAczh5V1X9Cmh1UZsGrmb6_33wJt2UulYn_9LRczrfYf0130_provenance.